Skip to main page content
U.S. flag

An official website of the United States government

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Search Results

37 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Neonatal meningitis: can we do better?
Heath PT, Okike IO, Oeser C. Heath PT, et al. Among authors: okike io. Adv Exp Med Biol. 2011;719:11-24. doi: 10.1007/978-1-4614-0204-6_2. Adv Exp Med Biol. 2011. PMID: 22125031 Review. No abstract available.
The COVID-19 Schools Infection Survey in England: Protocol and Participation Profile for a Prospective Observational Cohort Study.
Halliday KE, Nguipdop-Djomo P, Oswald WE, Sturgess J, Allen E, Sundaram N, Ireland G, Poh J, Ijaz S, Shute J, Diamond I, Rourke E, Dawe F, Judd A, Clark T, Edmunds WJ, Bonell C, Mangtani P, Ladhani SN, Langan SM, Hargreaves J; COVID-19 Schools Infection Survey Study Group. Halliday KE, et al. JMIR Res Protoc. 2022 Nov 10;11(11):e34075. doi: 10.2196/34075. JMIR Res Protoc. 2022. PMID: 35635843 Free PMC article.
Safety and immunogenicity of AS03B adjuvanted split virion versus non-adjuvanted whole virion H1N1 influenza vaccine in UK children aged 6 months-12 years: open label, randomised, parallel group, multicentre study.
Waddington CS, Walker WT, Oeser C, Reiner A, John T, Wilkins S, Casey M, Eccleston PE, Allen RJ, Okike I, Ladhani S, Sheasby E, Hoschler K, Andrews N, Waight P, Collinson AC, Heath PT, Finn A, Faust SN, Snape MD, Miller E, Pollard AJ. Waddington CS, et al. BMJ. 2010 May 27;340:c2649. doi: 10.1136/bmj.c2649. BMJ. 2010. PMID: 20508026 Free PMC article. Clinical Trial.
Open-label, randomised, parallel-group, multicentre study to evaluate the safety, tolerability and immunogenicity of an AS03(B)/oil-in-water emulsion-adjuvanted (AS03(B)) split-virion versus non-adjuvanted whole-virion H1N1 influenza vaccine in UK children 6 months to 12 years of age.
Waddington C, Andrews N, Hoschler K, Walker W, Oeser C, Reiner A, John T, Wilkins S, Casey M, Eccleston P, Allen R, Okike I, Ladhani S, Sheasby E, Waight P, Collinson A, Heath P, Finn A, Faust S, Snape M, Miller E, Pollard A. Waddington C, et al. Health Technol Assess. 2010 Oct;14(46):1-130. doi: 10.3310/hta14460-01. Health Technol Assess. 2010. PMID: 20923610 Free article. Clinical Trial.
The immunogenicity of a novel A (H1N1) vaccine in HIV-infected children.
Okike IO, Yung C, Ladhani S, Oeser C, Bennett A, Doerholt K, Storey S, Donaghy S, Butter N, Hoschler K, Sheasby L, Heath PT, Miller E. Okike IO, et al. Vaccine. 2011 Sep 2;29(38):6636-40. doi: 10.1016/j.vaccine.2011.06.103. Epub 2011 Jul 13. Vaccine. 2011. PMID: 21742005
Predictors of immune response and reactogenicity to AS03B-adjuvanted split virion and non-adjuvanted whole virion H1N1 (2009) pandemic influenza vaccines.
Andrews NJ, Walker WT, Finn A, Heath PT, Collinson AC, Pollard AJ, Snape MD, Faust SN, Waight PA, Hoschler K, Sheasby L, Waddington C, Kerridge S, Chalk J, Reiner A, John T, Fletcher M, Allen R, Fineman N, Wilkins S, Casey M, Michaelis L, Oeser C, Okike I, Ladhani S, Miller E. Andrews NJ, et al. Vaccine. 2011 Oct 19;29(45):7913-9. doi: 10.1016/j.vaccine.2011.08.076. Epub 2011 Aug 27. Vaccine. 2011. PMID: 21875635 Clinical Trial.
H1N1 antibody persistence 1 year after immunization with an adjuvanted or whole-virion pandemic vaccine and immunogenicity and reactogenicity of subsequent seasonal influenza vaccine: a multicenter follow-on study.
Walker WT, de Whalley P, Andrews N, Oeser C, Casey M, Michaelis L, Hoschler K, Harrill C, Moulsdale P, Thompson B, Jones C, Chalk J, Kerridge S, John TM, Okike I, Ladhani S, Tomlinson R, Heath PT, Miller E, Faust SN, Snape MD, Finn A, Pollard AJ. Walker WT, et al. Clin Infect Dis. 2012 Mar 1;54(5):661-9. doi: 10.1093/cid/cir905. Epub 2012 Jan 19. Clin Infect Dis. 2012. PMID: 22267719 Free PMC article. Clinical Trial.
Incidence, etiology, and outcome of bacterial meningitis in infants aged <90 days in the United kingdom and Republic of Ireland: prospective, enhanced, national population-based surveillance.
Okike IO, Johnson AP, Henderson KL, Blackburn RM, Muller-Pebody B, Ladhani SN, Anthony M, Ninis N, Heath PT; neoMen Study Group. Okike IO, et al. Clin Infect Dis. 2014 Nov 15;59(10):e150-7. doi: 10.1093/cid/ciu514. Epub 2014 Jul 4. Clin Infect Dis. 2014. PMID: 24997051
37 results